Literature DB >> 9586651

Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort.

R D Moore1.   

Abstract

The Johns Hopkins AIDS Service is the principal provider of medical care for HIV-infected patients in Maryland, a state in which the majority of HIV-infected patients live in an urban environment. A component of the HIV service at Johns Hopkins Medical Center is an information system that is used to track longitudinally the ambulatory and inpatient care of HIV-infected patients. Enrollment into this database coincides with first enrollment into the HIV Service. Extensive laboratory, diagnostic, clinical, and pharmaceutical information is collected at enrollment and is updated every 6 months. Outpatient and inpatient medical records, Johns Hopkins Health System automated databases, supplemental medical records from outside facilities, vital records, and patient and provider interviews are all used to obtain the detailed data that are stored on the database. The database also includes an economic component, which was added in 1994. This component links all Maryland state Medicaid claims data to that relating to patients who are insured by the Maryland Medical Assistance program, who account for approximately 60% of patients using the Johns Hopkins HIV Service. This data linkage facilitates detailed quantification of the costs of medical care for the HIV-infected patient throughout the course of the infection. We currently have data on about 3,000 HIV-infected patients representing a heterogeneous mix by race, sex, socioeconomic status, and risk factors for HIV transmission. Our data have been used to address a variety of issues regarding access to, utilization of, and clinical outcomes of HIV therapeutics. Clinical practice data such as ours will be increasingly important as the number and types of antiretroviral and other drugs for HIV infection continue to increase.

Entities:  

Mesh:

Year:  1998        PMID: 9586651     DOI: 10.1097/00042560-199801001-00011

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  93 in total

1.  Alcohol consumption among HIV-infected women: impact on time to antiretroviral therapy and survival.

Authors:  Robyn C Neblett; Heidi E Hutton; Bryan Lau; Mary E McCaul; Richard D Moore; Geetanjali Chander
Journal:  J Womens Health (Larchmt)       Date:  2011-01-31       Impact factor: 2.681

2.  Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland.

Authors:  Mohamed G Atta; Derek M Fine; Gregory D Kirk; Shruti H Mehta; Richard D Moore; Gregory M Lucas
Journal:  Clin Infect Dis       Date:  2007-12-15       Impact factor: 9.079

3.  HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithm.

Authors:  Matthew M Cousins; Jacob Konikoff; Oliver Laeyendecker; Connie Celum; Susan P Buchbinder; George R Seage; Gregory D Kirk; Richard D Moore; Shruti H Mehta; Joseph B Margolick; Joelle Brown; Kenneth H Mayer; Beryl A Koblin; Darrell Wheeler; Jessica E Justman; Sally L Hodder; Thomas C Quinn; Ron Brookmeyer; Susan H Eshleman
Journal:  J Clin Microbiol       Date:  2013-10-23       Impact factor: 5.948

4.  Measurement of Current Substance Use in a Cohort of HIV-Infected Persons in Continuity HIV Care, 2007-2015.

Authors:  Catherine R Lesko; Alexander P Keil; Richard D Moore; Geetanjali Chander; Anthony T Fojo; Bryan Lau
Journal:  Am J Epidemiol       Date:  2018-09-01       Impact factor: 4.897

5.  Antiretroviral Therapy Use, Medication Adherence, and Viral Suppression Among PLWHA with Panic Symptoms.

Authors:  Tanyka Suzanne Sam; Heidi E Hutton; Bryan Lau; Mary E McCaul; Jeanne Keruly; Richard Moore; Geetanjali Chander
Journal:  AIDS Behav       Date:  2015-11

6.  Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen Among Virally Suppressed Individuals.

Authors:  Keri L Calkins; Catherine R Lesko; Geetanjali Chander; Richard D Moore; Bryan Lau
Journal:  J Acquir Immune Defic Syndr       Date:  2018-03-01       Impact factor: 3.731

7.  Lower-sensitivity and avidity modifications of the vitros anti-HIV 1+2 assay for detection of recent HIV infections and incidence estimation.

Authors:  Sheila M Keating; Debra Hanson; Mila Lebedeva; Oliver Laeyendecker; N'ko L Ali-Napo; S Michele Owen; Susan L Stramer; Richard D Moore; Philip J Norris; Michael P Busch
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

8.  Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection.

Authors:  Gregory D Kirk; Jacquie Astemborski; Shruti H Mehta; Chuck Spoler; Cedric Fisher; Danisha Allen; Yvonne Higgins; Richard D Moore; Nezem Afdhal; Michael Torbenson; Mark Sulkowski; David L Thomas
Journal:  Clin Infect Dis       Date:  2009-04-01       Impact factor: 9.079

9.  Early mortality and cause of deaths in patients using HAART in Brazil and the United States.

Authors:  Beatriz Grinsztejn; Valdilea G Veloso; Ruth K Friedman; Ronaldo I Moreira; Paula M Luz; Dayse P Campos; José H Pilotto; Sandra W Cardoso; Jeanne C Keruly; Richard D Moore
Journal:  AIDS       Date:  2009-10-23       Impact factor: 4.177

10.  Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution.

Authors:  Ashwin Balagopal; Stuart C Ray; Ruben Montes De Oca; Catherine G Sutcliffe; Perumal Vivekanandan; Yvonne Higgins; Shruti H Mehta; Richard D Moore; Mark S Sulkowski; David L Thomas; Michael S Torbenson
Journal:  AIDS       Date:  2009-11-27       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.